Medical device maker Boston Scientific (NYSE: BSX) has reported a second-quarter net loss of $3.40 billion, or $2.39 per diluted share. Adjusted earnings were $0.11 per share, which compares with $0.10 per share in the same period a year ago. That also beat the consensus EPS estimate by a penny per share.
The company also said quarterly revenue declined to $1.83 billion from $1.97 billion in the year-ago quarter. That fell short of the average revenue estimate of $1.89 billion.
During the second quarter, the company recorded a noncash $3.4 billion estimated goodwill impairment charge associated with its Europe, Middle East and Africa reporting unit. This was primarily driven by lower projected long-term growth rates due to macroeconomic factors and its performance in the European market.
“Despite increased competition, challenging market dynamics and disappointing results in certain businesses during the quarter, we delivered on our adjusted earnings and continued to generate strong cash flow,” said CEO Hank Kucheman.
Shares are about 0.7% higher in premarket trading to $5.37. The 52-week trading range is $5.01 to $7.55. Thomson Reuters had a consensus analyst price target of $6.79 before this earnings release.
Competitor St. Jude Medical (NYSE: STJ) is down about 0.08% in premarket trading.
Are You Ahead, or Behind on Retirement? (sponsor)
If you’re one of the over 4 Million Americans set to retire this year, you may want to pay attention. Many people have worked their whole lives preparing to retire without ever knowing the answer to the most important question: are you ahead, or behind on your retirement goals?
Don’t make the same mistake. It’s an easy question to answer. A quick conversation with a financial advisor can help you unpack your savings, spending, and goals for your money. With SmartAsset’s free tool, you can connect with vetted financial advisors in minutes.
Why wait? Click here to get started today!
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Latest from 24/7
Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.
You can follow him investing $500,000 of his own money on our top AI stocks for free.